메뉴 건너뛰기




Volumn 201, Issue 1, 2000, Pages 79-88

Relations between crystallisation conditions and micromeritic properties of ibuprofen

Author keywords

Crystallisation; Eudragit polymers; Ibuprofen; Micromeritic properties

Indexed keywords

2 PROPANOL; ACETONE; ALCOHOL; EUDRAGIT; EUDRAGIT RS; IBUPROFEN; METHANOL; POLYMETHACRYLIC ACID DERIVATIVE; SOLVENT;

EID: 0034657401     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(00)00398-7     Document Type: Article
Times cited : (31)

References (15)
  • 1
    • 0342635325 scopus 로고    scopus 로고
    • 1993. Process for enhancing the flow characteristics of ibuprofen. US Patent 5191114, 2 March
    • Chen, J., 1993. Process for enhancing the flow characteristics of ibuprofen. US Patent 5191114, 2 March.
    • Chen, J.1
  • 2
    • 0343505659 scopus 로고    scopus 로고
    • 1984. Crystallization of ibuprofen. US Patent 4476248, 9 October
    • Gordon, R.E., Amin, S.I., 1984. Crystallization of ibuprofen. US Patent 4476248, 9 October.
    • Gordon, R.E.1    Amin, S.I.2
  • 3
    • 0033514529 scopus 로고    scopus 로고
    • Crystallisation of paracetamol in acetone-water mixtures
    • Granberg R.A., Bloch D.G., Rasmuson A.C. Crystallisation of paracetamol in acetone-water mixtures. J. Cryst. Growth. 198-199:1999;1287-1293.
    • (1999) J. Cryst. Growth , vol.198-199 , pp. 1287-1293
    • Granberg, R.A.1    Bloch, D.G.2    Rasmuson, A.C.3
  • 4
    • 0002357929 scopus 로고
    • Characterisation of the powder particle shape
    • Hausner H.H. Characterisation of the powder particle shape. Planseeber. Pulvermetall. 14:1966;75-84.
    • (1966) Planseeber. Pulvermetall. , vol.14 , pp. 75-84
    • Hausner, H.H.1
  • 5
    • 0041669526 scopus 로고
    • The scope of particle size analysis and standardization
    • Heywood H. The scope of particle size analysis and standardization. Inst. Chem. Eng. Suppl. 25:1947;14-24.
    • (1947) Inst. Chem. Eng. Suppl. , vol.25 , pp. 14-24
    • Heywood, H.1
  • 6
    • 0032415145 scopus 로고    scopus 로고
    • Crystallisation conditions and physicomechanical properties of ibuprofen - Eudragit S100 spherical crystal agglomerates prepared by the solvent-change technique
    • Kachrimanis K., Ktistis G., Malamataris S. Crystallisation conditions and physicomechanical properties of ibuprofen - Eudragit S100 spherical crystal agglomerates prepared by the solvent-change technique. Int. J. Pharm. 173:1998;61-74.
    • (1998) Int. J. Pharm. , vol.173 , pp. 61-74
    • Kachrimanis, K.1    Ktistis, G.2    Malamataris, S.3
  • 11
    • 0343941406 scopus 로고
    • Solution and phase equilibria
    • A. Osol. Pennsylvania: Mack Publishing Company
    • Sokolowski D.T. Solution and phase equilibria. Osol A. Remington's Pharmaceutical Sciences. 16th ed:1980;214-215 Mack Publishing Company, Pennsylvania.
    • (1980) Remington's Pharmaceutical Sciences 16th Ed , pp. 214-215
    • Sokolowski, D.T.1
  • 13
    • 0001497804 scopus 로고
    • One degree of freedom for non-additivity
    • Tukey J.W. One degree of freedom for non-additivity. Biometrics. 5:1949;232-242.
    • (1949) Biometrics , vol.5 , pp. 232-242
    • Tukey, J.W.1
  • 14
    • 0347426729 scopus 로고
    • Reply to query
    • Tukey J.W. Reply to query. Biometrics. 11:1955;111-113.
    • (1955) Biometrics , vol.11 , pp. 111-113
    • Tukey, J.W.1
  • 15
    • 0026556368 scopus 로고
    • Crystal engineering and particle design for the powder compaction process
    • York P. Crystal engineering and particle design for the powder compaction process. Drug Dev. Ind. Pharm. 18:1992;677-721.
    • (1992) Drug Dev. Ind. Pharm. , vol.18 , pp. 677-721
    • York, P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.